CTT Pharma insider buys 11,500 shares at $0.045
CTT PHARMACEUTICAL HOLDINGS, INC.
Rhea-AI Filing Summary
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) reported an insider purchase of its own common stock. On 2026-08-20, the reporting person acquired 11,500 shares of CTTH in an open market or private transaction at $0.045 per share, resulting in 9,378,656 shares held directly after the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 11,500 shares
Net Buy
1 txn
Insider
CTT PHARMACEUTICAL HOLDINGS, INC.
Role
CEO
Bought
11,500 shs ($517.50)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | CTTH | 11,500 | $0.045 | $517.50 |
Holdings After Transaction:
CTTH — 9,378,656 shares (Direct)
Key Figures
Shares purchased: 11,500 shares
Purchase price: $0.045 per share
Shares owned after transaction: 9,378,656 shares
3 metrics
Shares purchased
11,500 shares
CTTH common stock acquired on 2026-08-20
Purchase price
$0.045 per share
Price for CTTH shares in the reported transaction
Shares owned after transaction
9,378,656 shares
Direct CTTH holdings following the 2026-08-20 purchase
Key Terms
Form 4, open market or private transaction, Rule 10b5-1 trading plan
3 terms
Form 4 regulatory
"CTT Pharmaceutical Holdings, Inc. reported an insider transaction on Form 4"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
open market or private transaction financial
"Purchase in open market or private transaction"
Rule 10b5-1 trading plan regulatory
"The Rule 10b5-1 trading plan box is not checked"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
FAQ
What insider transaction did CTTH report on this Form 4?
CTT Pharmaceutical Holdings, Inc. reported a purchase of 11,500 CTTH shares on 2026-08-20 at $0.045 per share, increasing the insider’s direct holdings to 9,378,656 shares after the transaction.
Was the Form 4 transaction in CTTH stock a purchase or a sale?
The reported Form 4 transaction in CTTH stock was a purchase. The insider acquired 11,500 shares in an open market or private transaction at $0.045 per share on 2026-08-20.
Is the CTTH insider transaction reported under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 trading plan box is not checked. This means the 11,500-share CTTH purchase on 2026-08-20 was not affirmatively reported as made under a Rule 10b5-1 plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
